v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
REVENUE:        
Total revenue $ 537,102 $ 481,069 $ 865,913 $ 773,332
OPERATING COSTS AND EXPENSES:        
Cost of commissions and other services revenue 103,034 101,138 172,135 166,872
Cost of goods sold—pharmacy revenue 205,194 156,201 397,973 285,724
Marketing and advertising 105,028 97,725 166,975 161,489
Selling, general, and administrative 38,940 45,021 74,759 81,166
Technical development 9,595 10,044 19,506 19,119
Total operating costs and expenses 461,791 410,129 831,348 714,370
INCOME FROM OPERATIONS 75,311 70,940 34,565 58,962
INTEREST EXPENSE, NET (11,613) (23,721) (23,421) (46,752)
CHANGE IN FAIR VALUE OF WARRANTS 19,296 (7,642) 34,332 (7,642)
OTHER EXPENSE, NET (39) (21) (183) (32)
Loss before income tax benefit 82,955 39,556 45,293 4,536
INCOME TAX EXPENSE (BENEFIT) 13,662 (13,680) 6,459 (4,154)
NET INCOME 69,293 53,236 38,834 8,690
Senior Non-Convertible Preferred Stock accumulated dividends and accretion (18,125) 0 (35,607) 0
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 51,168 $ 53,236 $ 3,227 $ 8,690
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS PER SHARE:        
Basic (in dollars per share) $ 0.27 $ 0.31 $ 0.02 $ 0.05
Diluted (in dollars per share) $ 0.26 $ 0.30 $ 0.01 $ 0.05
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:        
Basic (in shares) 187,573 171,802 186,694 171,116
Diluted (in shares) 190,830 175,101 190,730 175,024
OTHER COMPREHENSIVE LOSS, NET OF TAX:        
Unrealized loss, net of related tax benefit for the three and six months ended December 31, 2025, and 2024, of $0.0 million and $0.1 million $ 0 $ (393) $ 0 $ (432)
Amount reclassified into earnings, net of related tax benefit for the three months ended December 31, 2025, and 2024, of $0.0 million and $0.3 million, and for the six months ended December 31, 2025, and 2024, of $0.0 million and $1.3 million. 0 (934) 0 (3,680)
OTHER COMPREHENSIVE LOSS 0 (1,327) 0 (4,112)
COMPREHENSIVE LOSS 69,293 51,909 38,834 4,578
Commissions and other services        
REVENUE:        
Total revenue 309,893 301,069 420,160 440,449
Pharmacy        
REVENUE:        
Total revenue $ 227,209 $ 180,000 $ 445,753 $ 332,883